Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Genscript Biotech Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genscript Biotech Corp
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Accrued Liabilities
$165.9m
CAGR 3-Years
11%
CAGR 5-Years
34%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Accrued Liabilities
ÂĄ2.2B
CAGR 3-Years
10%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Accrued Liabilities
ÂĄ732.6m
CAGR 3-Years
18%
CAGR 5-Years
30%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Accrued Liabilities
ÂĄ393.2m
CAGR 3-Years
-1%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Accrued Liabilities
ÂĄ346m
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
46%
W
WuXi XDC Cayman Inc
HKEX:2268
Accrued Liabilities
ÂĄ74.9m
CAGR 3-Years
109%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Genscript Biotech Corp
Glance View

Market Cap
23.3B HKD
Industry
Life Sciences Tools & Services

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Intrinsic Value
32.97 HKD
Undervaluation 67%
Intrinsic Value
Price

See Also

What is Genscript Biotech Corp's Accrued Liabilities?
Accrued Liabilities
165.9m USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Accrued Liabilities amounts to 165.9m USD.

What is Genscript Biotech Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
34%

Over the last year, the Accrued Liabilities growth was -11%. The average annual Accrued Liabilities growth rates for Genscript Biotech Corp have been 11% over the past three years , 34% over the past five years .

Back to Top